Currently, there is no cure for dementia - but is early screening the answer? We invite you to join our three eminent speakers who will discuss in-depth the benefits and dangers of early screening and early diagnosis. You'll hear three trans-cultural viewpoints as to whether early screening is warranted even before symptoms become evident.
Join the International Psychogeriatric Association (IPA), the Global Ageing Network (GAN), and INTERDEM, on 29 September 2021: Screening Early for Dementia: What are the Risks and Benefits? International speakers will share their expertise followed by a live Questions & Answer session.
As with all programs in the IPA Webinar Series, this presentation is intended as an educational event on topics that are timely and relevant to the field of mental health for older adults
Prof. Myrra Vernooij-Dassen, PhD
Chair, IPA Webinar Series
Program & Presenters-
William E. Reichman, MD
Baycrest and University of Toronto
Presentation: “There is no case for screening for MCI or dementia in the general population”
Dr. Frans Verhey, MD, PhD
University Hospital of Maastricht
Presentation: “Timely screening for dementia: why, what, and how"
Huali Wang, MD/PhD
Peking University Institute of Mental Health
Presentation: “Understanding Alzheimer’s disease and dementia within the African American community: the influence of culture on carrying the diagnosis of dementia"
Ishan C. Williams, PhD, FGSA
University of Virginia, School of Nursing
Prof Myrra Vernooij-Dassen, PhD
Radboud University Nijmegen Medical Centre
Chair, IPA Webinar Task Force
Nijmegen, The Netherlands
Robert Madan MD FRCPC
Deputy Chief of Staff, Baycrest,
Prof Maria I. Lapid, MD
Professor of Psychiatry
Mayo Clinic, Rochester, MN, United States
Katie Smith Sloan
President & CEO, LeadingAge
Executive Director, Global Ageing Network
Director, Global Ageing Network